Moderna, Inc.

Healthcare

NASDAQ:MRNA · NASDAQ Global Select

Market Cap $25.38B Beta 1.03 P/E (TTM) -7.9

$63.96 +4.01%

+$2.48 today

52W Low $22.28High $67.74

Vol 21.59M · Avg 6.53M

EPS (TTM) -$8.09Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+149.16%

Period High

$63.96

Period Low

$22.36

Latest

$63.96

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Revolution Medicines, Inc.

NASDAQ:RVMD

$34.84B

Jazz Pharmaceuticals plc

NASDAQ:JAZZ

$14.12B

BridgeBio Pharma, Inc.

NASDAQ:BBIO

$13.04B

Exelixis, Inc.

NASDAQ:EXEL

$13.01B

Madrigal Pharmaceuticals, Inc.

NASDAQ:MDGL

$11.64B

BioMarin Pharmaceutical Inc.

NASDAQ:BMRN

$10.54B

Bio-Techne Corporation

NASDAQ:TECH

$9.01B

Halozyme Therapeutics, Inc.

NASDAQ:HALO

$8.05B

Caris Life Sciences, Inc.

NASDAQ:CAI

$5.23B

Atrium Therapeutics, Inc.

NASDAQ:RNA

$217.24M

What is the latest MRNA filing?

The latest filing shown is 4 dated Jun 17, 2026.

How many recent filings does MRNA have?

Intrinsic Alpha currently shows 20 recent filings for MRNA.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.